Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Protagonist Therapeutics, Inc. (PTGX) vs TG Therapeutics, Inc. (TGTX)

Protagonist Therapeutics, Inc. and TG Therapeutics, Inc. are both Biotechnology companies. Protagonist Therapeutics, Inc. and TG Therapeutics, Inc. are of similar size ($8.9B and $8.8B). TG Therapeutics, Inc. trades at the lower P/E: 18.9× against 117×. TG Therapeutics, Inc. grew revenue faster over the last twelve months: 76.1% against 34.8%. TG Therapeutics, Inc. has the higher net margin (55.2% vs 29.4%) and the lower return on invested capital (10.7% vs 61.8%). Across the 21 metrics below, TG Therapeutics, Inc. leads on 12 and Protagonist Therapeutics, Inc. on 9.

Valuation

Metric PTGX TGTX Biotechnology median
P/E 116.99 18.89 7.88
P/S 33.37 10.18 11.47
P/B 11.18 13.48 2.52
Price to free cash flow 72.07 468.33 21.16
EV/EBITDA 153.05 61.31 0.74
EV/Sales 30.60 10.43 10.73
Earnings yield 0.85% 5.29% (28.84%)
Free cash flow yield 1.39% 0.21% (23.03%)

Profitability

Metric PTGX TGTX Biotechnology median
Gross margin 100.00% 82.37% 65.16%
Operating margin 20.69% 17.05% 0.00%
Net margin 29.40% 55.22% 0.00%
Free cash flow margin 46.31% 2.17% 0.00%
Return on equity 10.98% 100.28% (57.72%)
Return on assets 10.34% 37.70% (49.22%)
Return on invested capital 61.84% 10.69% 0.00%

Growth

Metric PTGX TGTX Biotechnology median
Revenue growth (TTM) 34.81% 76.08% 5.64%
EPS growth (last fiscal year) (148.46%) 1,746.67% —
Revenue growth, 5-year CAGR 9.96% 426.73% 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric PTGX TGTX Biotechnology median
Debt to equity 0.00 1.23 0.00
Current ratio 21.71 4.27 4.73
Net debt to EBITDA 3.49 0.86 0.96

Dividend

Metric PTGX TGTX Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric PTGX TGTX Biotechnology median
Market cap 8.88b 8.80b 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack